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Background: The effect of in vivo treatment with ursolic acid (UA) on glycemia in hyperglycemic rats and its
mechanism of action on muscle were studied.
Methods: The UA effects on glycemia, glycogen, LDH, calcium and on insulin levels were evaluated after glucose
tolerance curve. The β-cells were evaluated through the transmission electronmicroscopy. UAmechanism of ac-
tion was studied on muscles through the glucose uptake with/without speciﬁc insulin signaling inhibitors. The
nuclear effect of UA and the GLUT4 expression onmusclewere studied using thymidine, GLUT4 immunocontent,
immunoﬂuorescence and RT-PCR.
Results: UA presented a potent antihyperglycemic effect, increased insulin vesicle translocation, insulin secretion
and augmented glycogen content. Also, UA stimulates the glucose uptake through the involvement of the classi-
cal insulin signaling related to the GLUT4 translocation to the plasmamembrane as well as the GLUT4 synthesis.
These were characterized by increasing the GLUT4 mRNA expression, the activation of DNA transcription, the
expression of GLUT4 and its presence at plasma membrane. Also, the modulation of calcium, phospholipase C,
protein kinase C and PKCaM II is mandatory for the full stimulatory effect of UA on glucose uptake. UA did not
change the serum LDH and serum calcium balance.
Conclusions: The antihyperglycemic role of UA is mediated through insulin secretion and insulinomimetic effect
on glucose uptake, synthesis and translocation of GLUT4 by amechanism of cross-talk between calcium and pro-
tein kinases.
General signiﬁcance: UA is a potential anti-diabetic agent with pharmacological properties for insulin resistance
and diabetes therapy.© 2014 Elsevier B.V. All rights reserved.1. Introduction
D-Glucose is the major fuel for most cells and its homeostasis re-
quires an integrated control by the whole organism. Insulin is, by far,
the chief regulating element of glycemia and is secreted frompancreatic
β-cells induced by glucose [1]. Through binding to its receptors in differ-
ent tissues, insulin activates signaling pathways that involve a complexa, Centro de Ciências Biológicas,
ostal 5069, CEP: 88040-970,
5 48 3721 96 72.cascade of protein kinases and regulatory proteins that conduce to the
metabolic effects of insulin [2].
Skeletal muscle composes a large percentage of total bodymass and
is the major site for insulin-dependent glucose disposal. In this tissue,
insulin induces a redistribution of glucose transporter protein (GLUT4)
from the cell interior to the surface of plasma membrane, which ulti-
mately leads to a greater glucose uptake rate in the muscle cells [1].
The increase in GLUT4 exocytosis in response to insulin is triggered
through signaling via the insulin receptor that induces the downstream
activation of signaling pathways such as PI3K/AKT/PKB, PKCs and
CAP/CBL/TC10 [2]. Also, insulin mediates a wide spectrum of biological
responses acting through the MAPK pathways, including activation of
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and differentiation [2].
The GLUT4 translocation and glucose uptake can also be activated by
muscle contraction through signaling pathways that cross talk with the
classical insulin regulatory mechanisms of glucose uptake. Muscle
contraction involves increase in the intracellular calcium levels which
regulate several signaling pathways and metabolic events. The increase
in myocellular calcium concentrations has been proposed to be a signal
in the initiation of contraction-stimulated glucose transport and GLUT4
translocation. In addition, one or more of the calcium regulated in-
tracellular proteins may be involved in these processes and potential
candidates include calmodulin and the calmodulin-dependent protein
kinase II (CaMKII). Ca2+–calmodulin-dependent kinase II (CaMKII)
has been proposed to act as an intermediate component of the con-
traction as well as insulin-induced signaling cascades that result in
the translocation of GLUT4 vesicles to the plasma membrane, in-
creased GLUT4 expression and increased glucose uptake in the skeletal
muscle [3].
Several investigations have demonstrated that natural compounds
can potentiate insulin release and/or stimulate GLUT4 translocation
and glucose uptake [4–7]. The pentacyclic triterpenes are isoprenoids
derived from plant secondary metabolism and represent the major
constituents of several medicinal plants [8]. Ursolic acid (3-beta-
hydroxyurs-12-en-28-oic acid; UA), the most representative ursane-
type triterpenoid is being described as an anti-inﬂammatory, hepato-
protective, antitumoral and antidiabetic agent [9]. It is known that
ursolic acid has signiﬁcant action in glucose homeostasis, reduces
blood glucose levels in diabetic individuals, and improves the glucose
and insulin tolerance, increases insulin synthesis and release from pan-
creas and inhibits protein glycation [10]. However, the mechanism by
which the UA regulates glucose uptake at the level of the main tissues
responsible for the balance of blood glucose, such as skeletal muscle
and adipose tissue, is not fully described. Therefore, the aim of the
present study was to investigate the role of UA on glucose homeostasis
and the calcium involvement on the mechanism of action of this
triterpene on glucose uptake in soleus muscle.
2. Materials and methods
2.1. Chemicals
Bovine serum albumin (BSA), 2-(2-amino-3-methoxyphenyl)-4H-
1-benzopyran-4-one (PD 98059), colchicine, wortmannin, KN93, cyclo-
heximide, mouse anti-β-actin, acrylamide and bis-acrylamide, mouse
anti-β-actin, and anti-mouse conjugated to Cy3 were purchased from
Sigma-Aldrich (St. Louis,MO,USA). GLUT4 (sc-53566) antibodywas ob-
tained from Santa Cruz Biotechnology (California, USA). The peroxidase
conjugated goat anti-mouse IgG, the Immobilon™Western chemilumi-
nescent horseradish peroxidase (HRP) substrate and the enzyme-linked
immunosorbent assay (ELISA) for the quantitative determination of
rat insulin (catalogue no. EZRMI-13K) were obtained from Millipore
(St Charles, MO; Temecula, California, USA). [U-14C]-2-deoxy-D-
glucose (14C-DG), speciﬁc activity 9.25 GBq/mmol, thymidine
[methyl-14C], speciﬁc activity 1.7464 GBq/mmol and biodegradable
liquid scintillation ﬂuid were obtained from Perkin-Elmer Life and
Analytical Sciences (Boston, MA, USA). Chlorhydrate of lidocaine
was purchased from Neo Quimica (Anápolis, Goiás, Brazil). All other
chemicals were of analytical grade.
2.2. Isolation of UA and chemical characterization
Leaves of Rosmarinus ofﬁcinalis (1500 g) purchased from Quimer
Natural Products Industry were submitted to maceration in ethanol
(96%) for ﬁfteen days at room temperature (25 ± 2 °C). Thereafter,
the extract was ﬁltered and then concentrated under reduced pressure
at approximately 60 °C. This procedure was repeated three times. Afterremoving the solvent, the ethanol extract was dried by liophilization to
yielding 153 g of a greenish brown solid. The crude extract was subject-
ed to passage on a short silica gel 60 (Vetec‐63-230 mesh) columnwith
hexane, ethyl acetate and ethanol in order of polarity, to give three frac-
tions: hexane (HEX), ethyl acetate (EtOAc) and ethanol (EtOH). Part of
the EtOAc fraction (8.83 g)was submitted to the silica gel columneluted
with hexane–ethyl acetate gradient in increasing polarity, to give 33
fractions. Fractions 20–33 eluted with hexane–acetone solution
(8:2 v/v) were combined and puriﬁed by ﬂash chromatography (silica
gel 60 column; Vetec‐230–400 mesh) with isocratic elution (hexane:
acetone 4:1 v/v) to give ursolic acid (87mg). Ursolic acid was identiﬁed
by analysis of IR and NMR data and comparison with literature [11].
2.3. Experimental animals
Male albino Wistar rats, 50–55 days old (180–210 g), were used.
Rats were bred in the animal facility and housed in an air-conditioned
room (approximately 21 ± 2 °C) with controlled lighting (lights on
from 06:00 to 18:00 h). The animals were maintained with pelleted
food (Nuvital, Nuvilab CR1, Curitiba, PR, Brazil), while tap water was
available ad libitum. Fasted rats were deprived of food for 16 h but
allowed free access to water. All the animals were carefully monitored
and maintained in accordance with the local Ethical Committee for
Animal Use (Protocol CEUA-UFSC PP00414).
2.4. Oral glucose tolerance curve
Fasted rats were divided into three groups of six animals. Group I,
hyperglycemic rats that received glucose (4 g/kg; 8.9 M); Group II,
hyperglycemic rats that received the vehicle, 2.5% Tween 80; and
Group III, hyperglycemic rats that received the UA (0.1, 1 and
10 mg/kg). Glycemia was measured before any treatment (zero time).
Immediately, rats received the treatment (vehicle or UA) and after
30 min they were overloaded with glucose. The glucose tolerance curve
was initiated just after the glucose overload and then glycemia was
measured at 15, 30, 60 and 180 min. All treatments were administered
by oral gavage. A local anesthesia (chlorhydrate of lidocaine) was used
and bloodwas collected from the tail vein to determine glycemia by the
glucose oxidase method [12] and the serum insulin levels.
2.5. Insulin serum measurements
The insulin levels were measured by ELISA according to the
manufacturer's instructions. The range of values detected by this
assay was 0.2–10 ng/mL. The intra- and inter-assay coefﬁcients of
variation for insulin were 3.22 and 6.95, respectively, with a sensitivity
value of 0.2 ng/mL. Insulin levels were estimated by means of colori-
metric measurement at 450 nm with an ELISA plate reader (Organon
Teknika, Roseland, NJ, USA) through interpolation from a standard
curve. Samples were analyzed in duplicate and results were expressed
as ng of insulin serummL−1 [13].
2.6. Glycogen content measurements
The soleus muscle was harvested from hyperglycemic rats and
hyperglycemic rats treated with UA (0.1, 1 and 10 mg/kg) and the
glycogen content was determined after 180 min of glucose overload
(4 g/kg). The glycogenwas isolated from the tissue as described by [14]
and the results were expressed as mg of glycogen/g of tissue [15].
2.7. Studies on 14C-glucose uptake in rat soleus muscle
For the [U-14C]-2-deoxy-D-glucose (14C-DG) uptake, the muscles of
euglycemic fasted rats were used. Slices of muscle were distributed
(alternately left and right) between the basal and treated groups.
Themuscles were dissected, pre-incubated (30min) and then incubated
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position of 3 mM glucose, 122 mM NaCl, 3 mM KCl, 1.2 mM MgSO4,
1.3 mM CaCl2, 0.4 mM KH2PO4, and 25 mM NaHCO3 and bubbled with
O2/CO2 (95%:5%, v/v) until pH 7.4. UA (10−4, 10−5, 10−6, 10−7, 10−8,
10−9, 10−10 and 10−12 M) was added to the pre-incubation (30 min)
and incubation medium (60 min) in the presence or absence of 100 μM
HNMPA-(AM)3, 100 nM wortmannin, 1 μM colchicine, 2 mM EGTA,
50 μM BAPTA-AM, 1 μM nifedipine, 1 μM ﬂunarizine, 1 μM U73122,
10 μM KN93, 40 μM RO 318220, 350 μM cycloheximide or 50 μM PD
98059. 14C-DG (0.1 μCi/mL; 0.12 nM) was added to each sample during
the incubation. Samples were processed according to [16]. For total pro-
tein quantiﬁcation themethod of Lowry et al. [17] was used. The glucose
uptake results were expressed as nmol glucose units/mg of protein.
2.8. Studies on thymidine incorporation into DNA
For the [methyl-14C]-thymidine incorporation into DNA, slices of
soleusmusclewere distributed (alternately left and right) between con-
trol and treated groups. The muscles were dissected, and pre-incubated
(30 min) and incubated (60 min) at 37 °C in KRb buffer with O2/CO2
(95%:5%, v/v), pH 7.4. UA (1 nM) was added to the pre-incubation
(30 min) and incubation (60 min) medium. 14C-thymidine (0.5 μCi/mL)
was added into all samples during the incubation period. After incuba-
tion, muscles were rinsed in cold KRb and processed according to [15].
The results were expressed as cpm/μg of protein.
2.9. Polyacrylamide gel electrophoresis and immunoblotting analysis
For the whole muscle homogenates, soleus muscles were incubated
(105 min) with/without 1 nM UA and in the presence of 10 μM KN93,
homogenized in a lysis solution containing 2 mM EDTA, 50 mM Tris–
HCl pH 6.8, 4% (w/v) SDS and the total protein concentration deter-
mined. For the electrophoresis analysis, samples were dissolved in 25%
(v/v) of a solution containing 40% glycerol, 5% mercaptoethanol,
50 mM Tris–HCl, pH 6.8 and boiled for 3 min. Equal protein concentra-
tions were loaded onto 12% polyacrylamide gels and analyzed by SDS-
PAGE according to the discontinuous system of Laemmli [18] and trans-
ferred to nitrocellulose membranes for 1 h at 15 V in transfer buffer
(48 mM Trizma, 39 mM glycine, 20% methanol and 0.25% SDS).
The nitrocellulose membranes were incubated for 2 h in blocking
solution (TBS; 0.5 M NaCl, 20 mM Trizma, plus 5% defatted dried
milk) and then incubated overnight at 4 °C with anti-GLUT4 diluted
to a ratio of 1:500. Membranes were incubated for 2 h with anti-
rabbit IgG (1:1000) and immunoreactive bands were visualized
using the Immobilon™ Western chemiluminescence HRP substrate
kit [19]. Autoradiograms were quantiﬁed by scanning the ﬁlms with
a Hewlett-Packard Scanjet 6100C scanner and determining the optical
densities with an OptiQuant version 02.00 software (Packard Instru-
ment Company).
2.10. Immunoﬂuorescence analysis
Soleus muscles of in vitro incubation (105 min) with/without 1 nM
UA or in vivo treatment (harvested after 180 min of oral treatment
with 1 mg/kg UA) were ﬁxed with 4% paraformaldehyde, dehydrated
and embedded in parafﬁn, as described by [20]. Representative
blocks of parafﬁn-embedded tissues were cut into 5 μm lengths,
deparafﬁnized, rehydrated and placed in 10 mM citrate buffer for
8 min at 37 °C for antigen retrieval. Sections were submitted to a
block solution of 3% BSA and 1% Igepal in PBS for 1 h at 37 °C and incu-
bated overnight at 7 °C with mouse anti-GLUT4 (1:500) or mouse anti-
β-actin (1:7500). After several washes, sections were incubated for 1 h
at 37 °C with anti-mouse conjugated to Cy3 (1:500, Sigma) in the same
solution and then counterstained with DAPI. Sections were then
mounted in a FluorSave reagent (Calbiochem). The analysis of GLUT4
distribution in the tissue was merely qualitative (adapted from [21]).2.11. Transmission electron microscopy (TEM)
For the observation under the transmission electron microscope
(TEM), pieces of rat pancreas were incubated in the presence of UA
(1 nM) for 5 or 20 min and were ﬁxed overnight with 2.5% glutaralde-
hyde in 0.1 M sodium cacodylate buffer (pH 7.2) plus 0.2 M sucrose
[22]. The material was post-ﬁxed with 1% osmium tetroxide for 3 h,
dehydrated in a graded acetone series and embedded in Spurr's resin.
Then, thin sections were stained with aqueous uranyl acetate followed
by lead citrate according to [23]. Four replicates were prepared for
each experimental group; two samples per replicate were examined
under TEM (Jeol JEM1011 at 80 kV) at the Central Laboratory of Electron
Microscopy (LCME, UFSC, Brazil).
In order to evaluate the ratio of cytoplasmic insulin vesicles per β-
cell [24], an isolated islet was sectioned and the vesicles of β-cells
were counted. So, the total number of vesicles was divided by the num-
ber of β-cells in the islet. Similarities based on the comparison of indi-
vidual treatments with replicates suggested that the ultra-structural
analyses were reliable.
2.12. Real time PCR
Total ribonucleic acid was extracted from tissues using Trizol re-
agent (Invitrogen, Carlsbad, CA) according to themanufacturer's proto-
col. All RNA samples were rid of contaminating DNA by using DNA-free
reagents (Invitrogen, Carlsbad, CA) according to the manufacturer's
protocol. One μg of RNA was reversed transcripted with Superscript III
(Invitrogen). The real time PCR ampliﬁcation was performed using
2 μL of cDNA, speciﬁc primers for each gene and SyBR Green reagent
(Invitrogen), in a ﬁnal volume of 10 μL. The 2−(ΔΔCt) method [25] was
used to calculate the ΔΔCt values. Moreover, β-actin was used as inter-
nal control. The primer sequences used are as follows: GLUT4: Forward:
5′-CGCGGCCTCCTATGAGATAC-3′; reverse: 5′-CCTGAGTAGGCGCCAA
TGA-3′ β-actin; forward: 5′-TGTTACCAACTGGGACGA-3′; reverse: 5′-
GGGGTGTTGAAGGTCTCA-3′
2.13. Calcium serum measurements and lactate dehydrogenase
The calcium serum levels were determined after zero, 15, 30, 60 and
180 min. For serum extracellular lactate dehydrogenase (LDH) it was
measured after 180 min of oral UA treatment (0.1, 1 and 10 mg/kg).
Blood samples and the serum were used to determine extracellular
LDH activity. Also, the calcium levels were determined according to
the manufacturer's instructions [15].
2.14. Data and statistical analysis
Data were expressed as mean ± S.E.M. One and two-way analysis
of variance (ANOVA) followed by Bonferroni post-test or unpaired
Student's t-test were used to determine whether there were signiﬁcant
differences between groups. Differences were considered signiﬁcant at
p ≤ 0.05.
3. Results
3.1. Effect of UA on glycemia and insulin secretion
Fig. 1A and B shows the structure and the serumglucose levels of hy-
perglycemic rats after oral treatment with UA (0.1, 1 and 10 mg/kg).
This triterpene was effective in reducing glycemia in all doses tested
during the period studiedwhen comparedwith the hyperglycemic con-
trol group. The treatment with 0.1, 1 and 10 mg/kg showed a sustained
effect from 15 to 180min, improving signiﬁcantly the glucose tolerance
curve. In percentage terms, the compound reduced about 28, 27, 17 and
16% of serum glucose levels when compared to the respective time on
hyperglycemic group. Also, the presence of vehicle 2.5% Tween 80 did
Fig. 1. UA structure (A). Effect of UA on oral glucose tolerance curve (B) and on serum insulin secretion (C) in hyperglycemic rats. Transmission electron microscopy of control and stim-
ulated insulin granules (D). Values are expressed asmean± S.E.M.with n=5. Signiﬁcant at ***p b 0.001 and **p b 0.01 compared to the respective value for hyperglycemic control group.
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to the hyperglycemic group. As it was expected, the euglycemic control
group did not show a signiﬁcant change on the proﬁle of glycemia overthe time studied. Taking into account the antihyperglycemic effect of UA
after in vivo treatment, the serum insulin levels were determined in
fasted rats after an oral glucose overload. As it was expected, glucose
Fig. 2. Effect of UA on glycogen content from soleusmuscle in hyperglycemic rats 180min
after treatment by oral gavage. Values are expressed asmean± S.E.M. with n=5 for each
group. Statistically signiﬁcant at *p b 0.05 compared to the hyperglycemic control group.
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glucose. In addition, the treatmentwith UA signiﬁcantly potentiated the
insulin secretion induced by glucose at 15 min in hyperglycemic rats
(Fig. 1C). Moreover, as shown in Fig. 1D, insulin granules are present
in β-cells and accumulate around the plasma membrane. Also, after
pancreas incubation with UA 1 nM for 5 min, a reduction in the insulin
granules of about 24% was observed when compared with the respec-
tive hyperglycemic control. Additionally, after 20 min of incubation
UA was not able to modify the amount of insulin vesicles on β-cells
compared with the respective hyperglycemic control group. Also,
Table 1 shows the ratio of cytoplasmic insulin vesicles per β-cell from
the control and treated islets as represented on Fig. 1D.
3.2. Effect of UA on muscle glycogen content
Fig. 2 shows the effect of UA after in vivo treatment on muscle
glycogen content. The treatment of hyperglycemic rats with 0.1, 1 and
10 mg/kg UA increased signiﬁcantly the glycogen content in soleus
muscle 3 h after the oral treatment compared to the hyperglycemic con-
trol group. In addition, the effect of UAby oral gavage potently increased
glycogen content (around 2 fold), when comparedwith the hyperglyce-
mic control group.
3.3. Mechanism of action of UA on glucose uptake on soleus muscle and its
effect on thymidine incorporation into DNA
Following up these studies, the in vitro effect of UA (10−4, 10−5,
10−6, 10−7, 10−8, 10−9, 10−10 and 10−12 M) on glucose uptake in
the rat soleus muscle at 60min of incubation was carried out. The stim-
ulatory effect of UA on glucose uptake was signiﬁcant at 100, 10, 1, 0.1
and 0.001 nM and represented around 2.0, 2.5, 3.0, 3.0 and 3.1 fold
compared to the basal value at 60min, respectively (Fig. 3). Considering
that there were no statistical signiﬁcant differences among the lower
concentrations of UA, the concentration of 1 nM was chosen to study
the mechanisms of action of this triterpene.
To determine the mechanism by which UA induces the glucose up-
take in soleus muscle, the glucose uptake assay was performed with
100 nM wortmannin, a speciﬁc inhibitor of PI3K, 1 μM colchicine, a
microtubule-depolymerizing agent or 100 μM of HNMPA(AM)3, an
inhibitor of insulin receptor tyrosine kinase activity. In all cases, the
concentrations used were those previously assayed and published
using similar approach [16,26]. Fig. 4 shows that the increase on glucose
uptake by 1 nM UA was completely inhibited by wortmannin and
colchicine pretreatment, whereas no change was observed in the
presence of HNMPA(AM)3. When only the inhibitors were added to
the muscle samples, any signiﬁcant change on glucose uptake was ob-
served compared with the control group.
In order to characterize more precisely the metabolic effects of UA,
50 μM BAPTA-AM, an intracellular calcium chelator and 2 mM EGTA,
an extracellular calcium chelator were used to investigate the calcium
involvement on glucose uptake. As it can be seen on Fig. 5A, in the pres-
ence of each chelator, EGTA and BAPTA-AM, the stimulatory action of
UA on glucose uptake was abrogated. Also, in order to verify the partic-
ipation of T- and L-type voltage-dependent calcium channels (L-VDCC)Table 1
The ratio of cytoplasmic insulin vesicles per β-cell in the presence of 1 nMUA (treated) or
absence (control) in the ﬁrst and second phases of insulin secretion. Incubation time = 5
and 20 minwith/without UA. n = 29 β-cells of one islet for hyperglycemic control group
at 5 min; n = 29β-cells of one islet for hyper + UAgroup at 5 min;n = 16β-cells of one
islet for hyperglycemic control group at 20 min and n = 23 β-cells of one islet for
hyper + UA at 20 min. Triplicates of each group were analyzed.
Time 5 min 20 min
Hyper Hyper + UA Hyper Hyper + UA
Cytoplasmic vesicles/cell 4.03 0.96 1.62 1.65on the mechanism involved in the UA action on glucose uptake, 1 mM
ﬂunarizine and 1 μM nifedipine were used to block these channels,
respectively. The results showed that nifedipine and ﬂunarizine
completely blocked the UA-stimulated glucose uptake (Fig. 5B).
Since the results indicated that the intracellular calcium levels and
extracellular calcium inﬂux through T- and L-type voltage-dependent
calcium channels (L-VDCC) are involved in the glucose uptake, it was
also sought to determine whether other intracellular pathways could
play a role on the stimulatory effect of UA on glucose uptake. The use
of 1 μMU73122, 10 μMKN93, 40 μM RO318220 allowed us to corrobo-
rate the participation of PLC, PKCaM II (a calcium-dependent kinase)
and atypical protein kinase C (aPKC) in the mechanism of action of UA
(Fig. 5C).
To determine whether the UA signal transduction leads to nuclear
actions, such as the MAPK pathways, genic expression and/or general
protein synthesis we examined the effect of PD 98059, an inhibitor of
MEK/ERK pathway, and the effect of cycloheximide on glucose uptake
stimulated byUA aswell as the action of UAonGLUT4mRNAexpression
(Fig. 6A and B). The stimulatory effect of UA was completely blocked in
the presence of PD98059 while cycloheximide was not able to alter the
UA-induced glucose uptake in muscle. Also, by RT-PCR, we observed
that UA stimulated the increase of GLUT4mRNAexpression in this period
of incubation. Moreover, the thymidine incorporation in rat soleus mus-
cle also was increased in the presence of UA when compared to the con-
trol group (Fig. 6C). These results indicate that UA may act through the
nuclear activity and the MAPK pathways, both of them are also involved
in the insulin phosphorylation cascades.Fig. 3. Concentration–response curve of UA on [14C]-glucose uptake in rat soleus muscle.
Pre-incubation time = 30 min; incubation time = 60 min. Values are expressed as
mean ± S.E.M.; n = 6 in duplicate for each group. Signiﬁcant at **p ≤ 0.01 and
***p ≤ 0.001 in relation to control group.
Fig. 4. Effect of HNMPA-(AM)3, colchicine and wortmannin on the stimulatory action of
UA on [14C]-glucose uptake in rat soleus muscle. Control group = no treatment.
Pre-incubation time = 30 min; incubation time = 60 min. Values are expressed as
mean ± S.E.M.; n = 6 in duplicate for each group. Signiﬁcant to **p ≤ 0.01 in relation to
control group. Signiﬁcant to #p ≤ 0.05 and ##p ≤ 0.01 in relation to UA group.
Fig. 5.Effect of EGTA, BAPTA-AM(A), nifedipine,ﬂunarizine (B), U73122, KN93, RO318220
(C) on the stimulatory action of UA on [14C]-glucose uptake in rat soleus muscle. Control
group= no treatment. Pre-incubation time= 30 min; incubation time= 60min. Values
are expressed asmean± S.E.M.; n=6 in duplicate for each group. Signiﬁcant to *p≤ 0.05
and **p ≤ 0.01 in relation to basal group. Signiﬁcant to #p ≤ 0.05, ##p ≤ 0.01 and
###p ≤ 0.001 in relation to UA group.
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Fig. 7A shows thewhole GLUT4 immunocontent onmuscle. A signif-
icant increase in the whole GLUT4 in the presence of UA (about 30%)
was observed after 105 min of in vitro incubation. 10 μM KN93
was not able to modify the basal GLUT4. However, in the presence of
the triterpene it nulliﬁed the stimulatory effect of UA on GLUT4
immunocontent. The acute effect of the positive control, insulin, pre-
sented the most prominent effect on the GLUT4 content (increased
76%) (data not shown). In addition, the localization of GLUT4 onmuscle
after in vitro treatment (105 min) with UA (panel B) and also for UA
after in vivo treatment (180min (panel D)) was investigated by ﬂuores-
cence (Fig. 7B). The presence of GLUT4 at plasmamembrane was mark-
edly increased by 1 nMUA at 105min (in vitro) incubation aswell as by
1 mg/kg UA at 180 min (in vivo) treatment compared with respective
basal group (panel A and C). The negative control, performed by incu-
bating the slices without primary anti-GLUT4 antibody, demonstrates
GLUT4 immuno negative reaction (panel E). This qualitative analysis is
in line with the effect of UA on whole GLUT4 immunocontent, reinforc-
ing the results showed in Fig. 7A.
3.5. Effect of UA on calcium and LDH serum levels
In order to verify a potential toxicity of this compound, the LDH and
calcium serum levels were evaluated after the oral treatment with UA.
The doses 0.1, 1 and 10 mg/kg orally administrated were not able to
change neither extracellular LDH (Fig. 8A) nor calcium serum levels
(Fig. 8B), indicating that in this experimental condition the UA by oral
gavage was not able to exhibit toxic effects.
4. Discussion
Ursolic acid, an ursane pentacyclic triterpene has been described to
inﬂuence carbohydrate metabolism [9,27,28,10]. In the present study,
the antihyperglycemic effect of UA indicated that this compound can
control hyperglycemia since it signiﬁcantly reduced serum glucose
concentrations, potentiated the glucose effect on insulin releasing and
maintained high insulin levels throughout the period studied. This is
in line with the results observed by Jang et al. [9] and Jayaprakasam
et al. [29] who showed signiﬁcant increases on insulin levels with thepreservation of pancreatic β-cells and modulation of blood glucose
levels in diabetic mice and C57BL/6 obese mice after a dietary UA sup-
plementation. Additionally, other triterpenes have also been shown to
Fig. 6. Effect of cycloheximide and PD98059 on stimulatory effect of UA on 14C-glucose
uptake in muscle (A), effect of UA on GLUT4 mRNA expression (B) and effect of UA on
14C-thymidine incorporation into soleus muscle (C). Pre-incubation time= 30min; incu-
bation time= 60min. Values are expressed as mean ± S.E.M. with n = 6 in triplicate for
each group. Signiﬁcant at **p b 0.01 compared to the control group. Signiﬁcant at
###p b 0.001 compared to UA group.
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β-amyrin and oleanolic acid [9,30–32,15]. All together, our data suggest
that UA acts by increasing the insulin secretion stored at vesicles and
induces translocation of granules pointing to an immediate effect of
the triterpene on the ﬁrst phase of insulin secretion. It's worthwhile to
mention that the doses assayed on oral gavage treatment with UA
were supported by the oral bioavailability of UA nanoparticles using
supercritical anti-solvent process reported by Yang et al. [33]. These
authors described that after 1 h of 100 mg/kg UA by gavage around
63.7 nM was bioavailable in the plasma (very close to the dose that
stimulates the glucose uptake 100 nM in our conditions). Furthermore,
UApotentiates the glucose-induced insulin secretion as characterized in
the proﬁle of serum insulin levels in this approach.In tissues such as skeletal muscle and liver, insulin promotes glucose
uptake and glycogen synthesis, constituting an importantmechanism of
glycemic control [1]. The UA signiﬁcantly increased the glycogen con-
tent in the skeletal muscle which is in line with its effect on liver glyco-
gen content after an in vivo treatment [27]. As previously demonstrated,
several triterpenes show to inﬂuence glycogen metabolism, especially
through the inhibition of muscle glycogen phosphorylase activity or
increase on AMPK and GSK-3β phosphorylation [34–38]. Therefore,
the increase in muscle glycogen deposition associated with higher
serum insulin levels induced by UA contributes to the serum glucose
lowering observed in hyperglycemic rats.
The results presented herein imply UA as an anti-diabetic agent,
however the mechanisms by which this compound ameliorates the
glycemia remain to be completely elucidated. UA signiﬁcantly stimulat-
ed glucose uptake in skeletal muscle and its effect was inhibited by
wortmannin and colchicine pointing to an involvement of PI3K and
microtubules integrity for the UA-induced glucose uptake. It has been
demonstrated that the insulin induced-glucose uptake in muscle is
powered through signaling via insulin receptor, PI3K and cytoskeleton
integrity ending up to the translocation of GLUT4 and glucose uptake
[2,39]. Several triterpenes and its derivatives such as UA, pachymic
acid, betulinic acid, oleanolic acid and corosolic acid were demon-
strated to stimulate glucose uptake through the increase of the
auto-phosphorylation and/or activation of IRβ, PI3K, IRS1 and AKT,
components of the classical insulin signaling. Additionally, these
compounds were able to stimulate GLUT4 translocation in 3 T3-L1
adipocytes, CHO/HIR cells, skeletal muscle and in in vivo models
[40–44,5,15]. From our data, the IR tyrosine kinase activity on the
stimulatory effect of UA on glucose uptake seems not to be essential
to the complete activation of glucose uptake induced by UA, studied
in this experimental approach. This is in line with the results show-
ing that UA had no effect on IRβ auto-phosphorylation and on IR tyro-
sine kinase activity at concentrations up to 10 μg/mL (approximately
20 μM). The signiﬁcant activation of IRβ auto-phosphorylation by UA
was observed just at concentrations above 50 μg/mL (approximately
0.1 μM) [41]. Although UA seemed to not directly activate the IR at
low concentrations but signiﬁcantly stimulated the glucose transport,
it is supposed that UA can act through the inhibition of protein tyrosine
phosphatases that cause the dephosphorylation of signaling molecules
which helps to terminate insulin signaling [45]. Several triterpenes
and their derivativeswere described as potent inhibitors of the PTPases,
especially, PTP1B [44,46,47]. Taking this into account, we consider that
UAmay act like an insulin sensitizer, to elevate insulin receptor β phos-
phorylation indirectly (PTP1B inhibition?) or as an insulin mimetic
agent acting through the insulin cascade.
In addition to the role of the classical PI3K pathway on the stimula-
tory effect of UA on glucose uptake, the involvement of intracellular sec-
ond messengers potentially associated with insulin pathways that
enhance glucose uptake was investigated. As an important intracellular
signalingmolecule, calcium is necessary formuscle contraction and acts
as a secondmessenger in insulin dependent and independent pathways
that lead to glucose uptake [48,49]. In the skeletal muscle, the free cyto-
solic calcium levels are tightly controlled by the inﬂux from the extra-
cellular medium or the release from the sarcoplasmic reticulum [50].
It has been demonstrated that insulin increases intracellular Ca2+ levels
involving both, extracellular and intracellular calciummobilizations and
this effect is positively correlated with the insulin-induced glucose up-
take in muscle [51,49,52]. Also, insulin induces an increase at near-
membrane calcium concentration through an L-type calcium channel
dependent mechanism and the induced glucose uptake is attenuated
by L-type Ca2+ channel blockers [53,54,51]. Our ﬁndings indicated
that the UA-induced glucose uptake can result from extracellular
calcium aswell as from cytosolic calciummobilization since the calcium
chelationwith BAPTA-AM and EGTA completely blocked its stimulatory
effect on glucose uptake. This result agrees with those reported for
oleanolic acid, asiatic acid and maslinic acid that increased cellular
Fig. 7. Effect of UA onwhole GLUT4 immunocontent (whole tissue extract) in soleusmuscle. KN93 10 μMwas present during incubation (105min)medium, in the presence or absence of
UA 1 nM. β-actin was used as loading control (A). Representative immunoblot is shown. Values are expressed as mean ± S.E.M. n = 4 for three independent experiments. Signiﬁcant at
**p b 0.001 compared with control group. Signiﬁcant at #p b 0.05 compared to UA group. Immunolocalization of GLUT4 on soleusmuscle (B). At 105min, in vitro: panel A (basal), panel B
(1 nMUA). At 180min, in vivo treatment: panel C (basal), panel D (1 mg/kg UA) and panel E (immunonegative reaction for GLUT4). imunocontrol-NC). GLUT4was stainedwith Cy3, and
immunoﬂuorescence revealed the presence of GLUT4 at plasma membrane of muscles treated 1 nM or 1 mg/kg UA (arrows). Nuclei were stained with DAPI (blue).
58 A.J.G. Castro et al. / Biochimica et Biophysica Acta 1850 (2015) 51–61
Fig. 8. Effect of UA on serum lactase dehydrogenase (A) and on serum calcium (B). Values
are expressed as mean ± S.E.M. with n = 5 for each group.
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Ca2+ release [55–57]. Also, the data reported herein suggest that
UA-induced glucose uptake depends on the inﬂux of calcium through
T- and L-type voltage-dependent calcium channels (L and T-VDCC) as
already described for UA on cardiac muscle cells and as well as for
rutin in skeletal muscle [58,59].
Besides the opening of calcium channels at plasma membrane, the
release of Ca2+ from the internal store – usually the endoplasmic retic-
ulum (ER) – represents another important mechanism involved in
increased cytosolic calcium levels to change cell behavior. This process
can be induced by Ca2+ itself (calcium-induced calcium release) and/or
by an expanding group ofmessengers, such as inositol-1,4,5-trisphospate
(IP3), that either stimulate or modulate the releasing of calcium from in-
ternal stores [50]. The synthesis of inositol-1,4,5-trisphospate (IP3) is
driven by a family of phospholipase C enzymes which are activated
through differentmechanisms and stimuli [60]. There is evidence that in-
sulin activates phospholipase C (PLC) in a PI3K-dependent manner,
which generates the second messengers diacylglycerol (DAG) and IP3
from phosphatidylinositol-4,5-bisphosphate (PIP2). The former functions
to activate PKCs and the latter stimulates the Ca2+ release from stores
[61–63]. Several studies suggest that PLC plays a role in insulin-
stimulated GLUT4 translocation and glucose uptake probably acting
through the generation of DAG and IP3which leads to the subsequent ac-
tivation of PKCζ and to the increase on cytosolic [Ca2+] fromendoplasmic
reticulum [61–66]. Our results indicate that the stimulatory effect of UA
on glucose uptake involves the PLC and aPKCs activities probably through
PI3K and calcium-dependent mechanisms. These are in line with thoseabove-proposedmechanisms bywhich insulin and contraction stimulate
glucose uptake. Additionally, triterpenes were shown to stimulate PLC
and PKC activities as well as calciummobilization in platelet aggregation
[56,67,68]. As far as we know, this is the ﬁrst report on triterpenes, espe-
cially UA, acting through PLC, aPKCs and cytosolic calcium to stimulate
glucose uptake in skeletal muscle.
Considering that the increase on calcium concentration inside the
cells can lead to calcium-calmodulin complex formation with subse-
quent CaMKII activation [69] the involvement of this kinase was also in-
vestigated on UA induced-glucose uptake in soleus muscle. CaMKII is
the predominant isoform expressed in skeletal muscle it is activated
and autophosphorylated by calcium-calmodulin complex [69,48,3].
The Ca2+–CaMKII signaling network can be established as a conver-
gence point for contraction and insulin-mediated glucose uptake. The
activation of CaMKII has been reported to stimulate cell surface GLUT4
translocation and the glucose uptake [70–72,52,73,74]. Additionally,
the activated CaMKII also regulates GLUT4 expression. The CaMKII has
been described to phosphorylate and inﬂuence the MAPK–MEK–
ERK1/2 activation [75,3] and also to modulate increases in the binding
of myocyte enhancer factor 2 (MEF2) and GLUT4 enhancer factor
(GEF) to their binding sites on the Glut4 gene leading to increased
GLUT4 synthesis. Smith et al. [76,77] demonstrated that the GLUT4
mRNA and the GLUT4 protein levels were increased after exercise in
in vivo experiments and these effects were inhibited in the presence of
KN93 indicating that CaMKII activity during exercise is required for
full expression of GLUT4. Our ﬁndings demonstrated the participation
of CaMKII in glucose uptake induced by UA. This protein is a potential
mediator for nuclear activity altered by UA that signiﬁcantly stimulated
the GLUT4 mRNA expression, thymidine incorporation into DNA and
also blocked the stimulatory effect of UA on GLUT4 immunocontent.
Additionally, the stimulatory effect of UA on glucose uptake involves
the MAPK pathway which is in accordance to the increased GLUT4
content in muscle after the in vitro treatments. Also, Although UA oral
treatment was carried out in a short-term it did not exhibit cell toxicity
or calcium unbalance showing additional physiological advantage for
this nutraceutical compound.
The inﬂuence of triterpenes on GLUT4 expressionwas previously re-
ported by our group for betulinic acid, which was able to up regulate
GLUT4 immunocontent in the skeletal muscle through the involvement
of MAPK pathway and inﬂuencing the overall protein synthesis in mus-
cle [15]. Similar results were also described for another triterpene,
pachymic acid, which increased the GLUT4 expression in 3 T3-L1 adipo-
cytes after an in vitro treatment [42]. Based on the present results, UA
seems to have amultitude of cellular targets considering glucosemetab-
olism. It's important to note that from this study there is a long research
that will come from the relevant data described herein. It involves a
series of research tools such as RT-PCR and immunoblotting of some
selected kinases, immunoﬂuorescence of some proteins engaged specif-
ically in GLUT4 translocation and anchoring at plasma membrane as
well as a strong effort on ionic involvement through electrophysiology
and patch clamp studies in order to investigate more deeply the details
of UA on glucose homeostasis.”
5. Conclusions
In summary, UA regulates glucose homeostasis involving insulin
secretion and insulin sensitizing with calcium participation in its mech-
anism of action. UA stimulates glucose uptake through a cross talk
between different signaling pathways, linking the PI3K andMAPK path-
ways with Ca2+–CaMKII network in intracellular translocation steps as
well as in GLUT4 expression in skeletal muscle.
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